PULM · Pulmatrix, Inc.
$1.77
+0.08 (+4.73%)
At close · Jul 23
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management believes that, given the Company’s current cash position and forecasted negative cash flows from operating activities over the next twelve months, there is substantial doubt about its ability to continue as a going concern after the date that is one year from the date that these financial statements are issued without the closing of the Merger.”View the 10-Q filed May 15, 2026
Market Cap
$6.03M
Shares
3.65M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.77
Open$1.67
Day$1.67–1.80
52W$1.16–6.15
Avg vol 30d79K
Short int27K · 0.8% float · 1.0d
Short vol8%
Last earningsNov 13, 2024
DataJan 2020–Jul 2026
Filing10-Q · May 15
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 15, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Weak
Sentiment
Bullish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 18.6 · elevated
Equity put/call 0.79
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−32%
below
Price vs 50-day avg
+18%
above
RSI (14)
62
neutral
MACD trend
Negative
52-week position
12%
near low
Momentum
relative strength
1-month return
+16%
trailing
6-month return
−32%
trailing
YTD return
−21%
this year
Relative strength
−39%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $3 — 200d above 50d
Institutional flow
Accumulating
2 of 15 funds reported for Jun 30 · net +1.2K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.75% of float · ▼ -69.9% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
15 holders — mid 3-yr range
Squeeze score
37
low risk · 0–100
Fundamentals
Revenue growth
+5070%
Y/Y
EPS growth
+46%
Y/Y
Free cash flow
$-5.8M
Balance sheet
$871.0K
net cash
Quant / Vol
risk profile
Volatility
86%
annualized · 1-yr
Max drawdown
−80%
past year
ATR
6.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−32%
Bearish
Price vs 50-day avg
+18%
Bullish
RSI (14)
62
Neutral
MACD trend
Negative
Bearish
52-week position
12%
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $2 › 200d $3 — 200d above 50d
Institutional flow
Accumulating
2 of 15 funds reported for Jun 30 · net +1.2K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.75% of float · ▼ -69.9% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
15 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $1
Now $2 · 12%
52-wk high $6
vs 200-day avg -32%
vs 50-day avg +18%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PULM
this stock
Pulmatrix, Inc.
|
$6.03M | -20.6% | -54.3% | — | 0.8% |
|
ONC
BeOne Medicines Ltd.
|
$471.01B | +7.6% | +22179.2% | 958.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$121.16B | +4.4% | +46.2% | 28.3 | 2.0% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$68.78B | -15.4% | +20.8% | 16.0 | 3.3% |
|
ARGX
Argenx SE
|
$57.44B | +9.9% | — | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PULM | +9.9% | +15.7% | -32.4% | +4.1% | -20.6% |
| SPY | -1.7% | +0.7% | +6.4% | -1.2% | +8.3% |
| vs SPY | +11.6% | +15.0% | -38.8% | +5.3% | -28.9% |